Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vagifem Low Dose Endometrial Safety Trial
NCT00431132Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2007
- Primary completion
- Nov 2008
- Modality
- Hormone, Biologic
- Countries
- 7
01
Overview
Phase 3, open-label, single-arm trial of estradiol in atrophic vaginitis, sponsored by Novo Nordisk. Primary endpoint: Endometrial Hyperplasia Based on Histological Assessment of Endometrial Biopsies at 52 weeks. Started Jan 2007; status: completed.
02
Drugs
estradiol
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on NCT00431132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431132.